ANTONAZZO IPPAZIO COSIMO

Losa, L., Antonazzo, I., Di Martino, G., Mazzaglia, G., Tafuri, S., Mantovani, L., et al. (2024). Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression. VACCINES, 12(5) [10.3390/vaccines12050527]. Detail

Antonazzo, I., Rozza, D., Conti, S., Fornari, C., Cortesi, P., Eteve-Pitsaer, C., et al. (2024). Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database. EUROPEAN JOURNAL OF NEUROLOGY, 31(1 (January 2024)) [10.1111/ene.16064]. Detail

Ferrara, P., Antonazzo, I., Zamparini, M., Fornari, C., Borrelli, C., Boarino, S., et al. (2024). Epidemiology of SLE in Italy: an observational study using a primary care database. LUPUS SCIENCE & MEDICINE, 11(1) [10.1136/lupus-2024-001162]. Detail

Fornari, A., Antonazzo, I., Rocino, A., Preti, D., Fragomeno, A., Cucuzza, F., et al. (2024). The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey. HAEMOPHILIA, 30(2), 449-462 [10.1111/hae.14926]. Detail

Cortesi, P., Antonazzo, I., Palladino, P., Gnesi, M., Mele, S., D’Amelio, M., et al. (2024). Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis. ACTA DIABETOLOGICA [10.1007/s00592-024-02276-3]. Detail